Skip to main content

Assessment of ARIA Sufficiency: Wayrilz (rilzabrutinib)

    Basic Details
    Approval Date
    Friday, August 29, 2025
    Original Posting Date
    Health Outcome(s)
    adverse pregnancy and fetal outcomes